Keiji Fujioka, Takeshi Hirasawa, Masako Kajihara, Akihiko Sano, Shuichi Sugawara, Yosuke Urabe: Controlled release drug formulation of open end cylindrical rod form. Dow Corning Asia, Sumitomo Pharmaceuticals, Birch Stewart Kolasch and Birch L, December 22, 1998: US05851547 (33 worldwide citation)

A drug formulation for producing sustained therapeutic efficacy, which releases at least one water-soluble drug over a prolonged period of time at a substantially constant rate wherein said drug formulation comprises

Hideo Nogusa, Hiroshi Hamana, Toshiro Yano, Masahiro Kajiki, Keiji Yamamoto, Satoshi Okuno, Shuichi Sugawara, Nobukazu Kashima, Kazuhiro Inoue: Polysaccharide derivatives and drug carriers. Drug Delivery System Institute, Wenderoth Lind & Ponack, November 18, 1997: US05688931 (21 worldwide citation)

A novel polysaccharide derivative, a drug carrier comprising a novel polysaccharide derivative, and a drug complex are disclosed. The polysaccharide derivative according to the present invention comprises a polysaccharide having a carboxyl group in which a peptide chain is introduced at a part or al ...

Shuichi Sugawara, Masahiro Kajiki, Hiroshi Kuriyama, Nobuya Kitaguchi: Drug complex. Asahi Kasei Kabushiki Kaisha, Young & Thompson, October 1, 2002: US06458347 (14 worldwide citation)

Disclosed is a drug complex of a drug having a hydroxyl group, which is capable of controlling the rate of the release of the drug therefrom in blood, the drug complex being represented by the following formula (1):

Takao Kiyota, Shuichi Sugawara, Hiroshi Hayashi: Treatment of cerebral edema with ANP pharmaceutical compositions. Ashi Kasei Kogyo Kabushiki Kaisha, Lowe Price LeBlanc & Becker, April 20, 1993: US05204327 (13 worldwide citation)

A pharmaceutical composition and its use in the treatment of cerebral edema are provided wherein the composition comprises an atrial natriuretic peptide having an amino acid sequence of 28 amino acids and at least one pharmaceutically acceptable carrier, diluent or excipient.

Shuichi Sugawara, Hisatsugu Kaji, Masaaki Shimada: Abrasing apparatus using magnetic abrasive powder. Kureha Chemical Industry Company, Tohbu MX, Koda and Androlia, March 15, 1988: US04730418 (7 worldwide citation)

An abrasing apparatus including an annular barrel having an upper opening. The barrel is rotated around an exciting coil and is filled with magnetic abrasive powder which is arranged by magnetic flux generated by the exciting coil to form magnetic brush. A work is embedded into the magnetic brush. T ...

Chiwane Ishikawa, Shuichi Sugawara: Oil sand treating system. Kureha Kagaku Kogyo Kabushiki Kaisha, Wegner & Bretschneider, April 28, 1981: US04264431 (7 worldwide citation)

Residue of distillation, preferably under reduced pressure of oil sand bitumen is thermally treated in a liquid state at a temperature of 350.degree.-450.degree. C. by blowing thereinto an inert heating medium, preferably a superheated steam at a temperature of not lower than the temperature of the ...

Mitsuru Ueda, Shinji Ando, Jin gang Liu, Yuzi Shibasaki, Yasuhiro Nakamura, Shuichi Sugawara, Miwa Ariyuki, Yuichi Eriyama, Keisuke Kuriyama, Hideaki Takase: Resin composition, cured product and optical parts. Tokyo Institute of Technology, JSR Corporation, Oblon Spivak McClelland Maier & Neustadt L, May 11, 2010: US07714096

It is provided for a resin composition including (A) at least one polyamic acid having the structure represented by the following formula (1): wherein R1 is independently an alkyl group having 1 to 3 carbon atoms or a cyano group; a is independently an integer of 0 to 4; R is a tetravalent organic g ...

Shuichi Sugawara, Kenji Osumi: Production method of 11-sugar sialylglycopeptide. The Noguchi Institute, Greenblum & Bernstein, August 19, 2014: US08809496

It is an object of the present invention to provide a method for producing an 11-sugar sialylglycopeptide easily and with good yield and a high degree of purity on an industrial scale from defatted bird egg yolks. The present invention provides a production method of an 11-sugar sialylglycopeptide. ...

Toshiaki Saitoh, Yukinari Inoue, Shuichi Sugawara, Hiroto Nishida, Yuuichi Oomura, Hideyasu Uchiyama, Ko Kondo: Wearable apparatus. PANASONIC INTELLECTUAL PROPERTY MANAGEMENT, Greenblum & Bernstein, July 19, 2016: US09395750

A wearable apparatus includes a flexible display device, and a flexible housing that holds the peripheral portion of the flexible display device. The flexible display device is disposed on the uppermost surface of the apparatus to serve as a reference for defining the total length of the apparatus, ...

Shuichi Sugawara: Body fluid compatible and biocompatible resin. Asahi Kasei Kabushiki Kaisha, Birch Stewart Kolasch & Birch, January 4, 2011: US07863408

A body fluid compatible and biocompatible resin for use in a medical treatment involving a contact of said resin with at least one member selected from the group consisting of a body fluid and a biological tissue, which comprises at least one substituted oxyalkylene polymer having a weight average m ...